The Donor – Recipient Weight Ratio is a Reliable Marker for Cell Yield in Hematopoietic Stem Cell Donations
Abstract
(ISSN 2577-5820)
OBM Transplantation is an international peer-reviewed Open Access journal, which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 8 days from acceptance to publication (median values for papers published in this journal in 2021, 1-2 days of FREE language polishing time is also included in this period).
Special Issue
Bone Marrow Transplantation
Submission Deadline: October 30, 2020 (Open) Submit Now
Guest Editor
Gerhard Hildebrandt, MD, FACP
Professor of Medicine, Division Chief, Hematology & Blood and Marrow Transplantation, Adjunct Professor, Department of Microbiology, Immunology and Molecular Genetics, Markey Cancer Center, University of Kentucky, 800 Rose Street, CC404, Lexington, KY 40536-0093, USA
Research Interests: Hematology and blood marrow transplantation; blood cancer; amyloidosis; chronic lymphocytic leukemia (CLL); myelodyplastic syndrome; hematopoietic stem cell transplantation; graft versus host disease
Publication
The Donor – Recipient Weight Ratio is a Reliable Marker for Cell Yield in Hematopoietic Stem Cell DonationsAbstract Bone marrow transplants remain an import source of hematopoietic stem cells for patients suffering from specific diseases like aplastic anemia, for pediatric patients with malignant and non-malignant blood cell disorders, and for situations in which graft-versus-host disease (GvHD) is a concern. Identifying the optimal donor to [...] |
Donor Cell-Derived Acute Myeloid Leukaemia with 3q26.2 Involvement/MECOM Rearrangement ‐ A Case Report and Literature Reviewby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Donor cell-derived leukaemia (DCL) is an uncommon complication of allogeneic hematopoietic stem cell transplantation (HSCT). DCL might represent up to 5% of the post-HSCT disease relapses, but case numbers reported in the literature might underestimate the frequency. The leukemogenesis of DCL is not well understood due to the limited numbers [...] |
TOP